TG Therapeutics TGTX Return on invested capital

Return on invested capital at other companies

BiogenBIIB

4.6%-3.5pp

Rhythm Pharmaceuticals, Inc.RYTM

-197.9%-87.7pp

Mirum Pharmaceuticals, Inc.MIRM

-43.3%—

Vor BiopharmaVOR

-153.1%-5,641pp

Ultragenyx PharmaceuticalRARE

-475.4%+443pp

Shattuck Labs, Inc.STTK

-579.2%-1,580pp

FAQ

What is TG Therapeutics's return on invested capital?

TG Therapeutics (TGTX) reported return on invested capital of 21.4% in Q2 2026.

How has TG Therapeutics's return on invested capital changed year-over-year?

TG Therapeutics's return on invested capital decreased by 17.3% year-over-year, from 25.8% to 21.4%.

What is the long-term trend for TG Therapeutics's return on invested capital?

Over 3 years (2021 to 2025), TG Therapeutics's return on invested capital has grown at a -80.0% compound annual growth rate (CAGR), from -2,736.3% to 22%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.